George Washington Cancer Center — Washington D.C., District of Columbia

George Washington Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20037.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

George Washington Cancer Center has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, Metastatic Breast Cancer, Marginal Zone Lymphoma.

Sponsors: Stemline Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, University of Arizona.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for George Washington Cancer Center?

George Washington Cancer Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has George Washington Cancer Center conducted?

George Washington Cancer Center has 3 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Metastatic Breast Cancer, Marginal Zone Lymphoma.

Is George Washington Cancer Center accredited by Crixeo Health?

George Washington Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about George Washington Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.